Silicon Drugs & Intermediates Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Silicon Drugs & Intermediates Private Limited

Silicon Drugs & Intermediates Private Limited, a active private limited company, was established on 25 February 2011 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2011PTC072926. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.30 Cr and a paid-up capital of ₹2.63 Cr.

It upholds a compliant status. Employing 7 professional, Its leadership includes Addanki Siva Rama Prasad (Director), Gade Bakki Reddy (Director), Siva Nagi Reddy Vuyyuru (Director). Past directors included Addanki Siva Rama Prasad, Vadde Kiran, Vadde Naasaraiah. It holds ₹7.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H No. 2-52/2/24, Plot No 24, Sy No 60, Megha Hills Colony, Guttalabegumpet (V) Serilingampa, Lly, Hyderabad, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2011PTC072926

  • Registration Number

    072926

  • Incorporation Date

    25 February 2011

  • Authorized Capital

    ₹3.30 Cr

  • Paid-Up Capital

    ₹2.63 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.30 Cr
  • Paid Up Capital ₹ 2.63 Cr
  • Company Age 15 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.50 Cr
  • Revenue Growth **** -83.09%
  • Profit Growth **** 98.96%
  • Ebitda **** 99.62%
  • Net Worth -3.33%
  • Total Assets -16.37%
Company report

Silicon Drugs & Intermediates Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Silicon Drugs & Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Silicon Drugs & Intermediates Private Limited?
Current Directors
Name Designation Appointment Date Status
Addanki Siva Rama Prasad Director 25 Feb 2011 Current
Gade Bakki Reddy Director 25 Feb 2011 Current
Siva Nagi Reddy Vuyyuru Director 25 Feb 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Nov 2016 Past
Pramod Abcsdd Director 01 Oct 2017 Past
Pramod Abcsdd Director 26 Nov 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Silicon Drugs & Intermediates.

Silicon Drugs & Intermediates Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 83.09% decrease. The company also saw a substantial improvement in profitability, with a 98.96% increase in profit. The company's net worth dipped by a decrease of 3.33%.

Silicon Drugs & Intermediates revenue growth over time
Silicon Drugs & Intermediates profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -83.09%
*******
*******
*******
*******
Revenue from Operations
*******
 -76.35%
*******
*******
*******
*******
Total Assets
*******
 -16.37%
*******
*******
*******
*******
Profit or Loss
*******
 98.96%
*******
*******
*******
*******
Net Worth
*******
 -3.33%
*******
*******
*******
*******
EBITDA
*******
 99.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Silicon Drugs & Intermediates?

In 2021, Silicon Drugs & Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹75,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 7.50 Cr
Latest Charge Details
Date Lender Amount Status
16 May 2011 State Bank Of India ₹7.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Silicon Drugs & Intermediates?

Silicon Drugs & Intermediates has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Silicon Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silicon Drugs & Intermediates's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Silicon Drugs & Intermediates
Recent Activity within the Organization
  • Annual General Meeting

    The activity Silicon Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Silicon Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    A charge with State Bank Of India amounted to Rs. 7.50 Cr with Charge ID 10295192 was registered on 16 May 2011. was recorded as a recent event.

  • Director Appointment

    Progress on Addanki Siva Rama Prasad was appointed as a Director was appointed as a Director on 25 Feb 2011 & has been associated with this company since 15 years 1 month . was documented.

  • Director Appointment

    The activity Gade Bakki Reddy was appointed as a Director was appointed as a Director on 25 Feb 2011 & has been associated with this company since 15 years 1 month . was completed.

  • Director Appointment

    The activity Siva Nagi Reddy Vuyyuru was appointed as a Director was appointed as a Director on 25 Feb 2011 & has been associated with this company since 15 years 1 month . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Silicon Drugs & Intermediates Private Limited?

The CIN of Silicon Drugs & Intermediates Private Limited is U24100TG2011PTC072926.

Where is Silicon Drugs & Intermediates Private Limited headquartered?

Silicon Drugs & Intermediates Private Limited is headquartered at H No. 2-52/2/24, Plot No 24, Sy No 60, Megha Hills Colony, Guttalabegumpet (V) Serilingampa, Lly, Hyderabad, Telangana, 500081.

When was Silicon Drugs & Intermediates Private Limited incorporated?

Silicon Drugs & Intermediates Private Limited was incorporated on 25 February 2011.

Who are the current directors of Silicon Drugs & Intermediates Private Limited?

The current directors of Silicon Drugs & Intermediates Private Limited are

What is the primary industry of Silicon Drugs & Intermediates Private Limited?

The primary industry of Silicon Drugs & Intermediates Private Limited is Manufacturing.

Is Silicon Drugs & Intermediates Private Limited a listed company?

Silicon Drugs & Intermediates Private Limited is unlisted.

What is the capital structure of Silicon Drugs & Intermediates Private Limited?

The authorized capital of Silicon Drugs & Intermediates Private Limited is ₹3.30 Cr, and the paid-up capital is ₹2.63 Cr.

What is the compliance status of Silicon Drugs & Intermediates Private Limited?

The compliance status of Silicon Drugs & Intermediates Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available